Jian Li

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Mianyang Central Hospital, Second Hospital of Tianjin Medical University, Chongqing Public Health Medical Center, Tianjin Medical University, Medical University of Vienna, Chongqing Medical University · ORCID：0000-0001-7220-9514

发表论文 21 篇 · 总被引 358 次 · h-index 10

代表论文

• A Phase II Trial of Paclitaxel and Cisplatin in Patients With Advanced Squamous-Cell Carcinoma of the Esophagus (2008 · American Journal of Clinical Oncology · 被引 87)
• Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma (2021 · Molecular Therapy — Nucleic Acids · 被引 51)
• Reconstruction of Tumor-Induced Pelvic Defects With Customized, Three-Dimensional Printed Prostheses (2022 · Frontiers in Oncology · 被引 35)
• Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first‐line chemotherapy (2016 · Cancer Medicine · 被引 34)
• The activation of SIRT1 by resveratrol reduces breast cancer metastasis to lung through inhibiting neutrophil extracellular traps (2023 · Journal of drug targeting · 被引 22)
• Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach (2020 · BMC Cancer · 被引 21)